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Wemathematically modeled the receptor-dependent mitogen-
activated protein kinase (MAPK) signaling by incorporating the
regulation through cellular phosphatases. Activation induced the
alignment of a phosphatase cascade in parallel with the MAPK
pathway. A novel regulatory motif was, thus, generated, providing
for the combinatorial control of each MAPK intermediate. This
ensured a non-linear mode of signal transmission with the output
being shaped by the balance between the strength of input signal
and the activity gradient along the phosphatase axis. Shifts in this
balance yielded modulations in topology of the motif, thereby
expanding the repertoire of output responses. Thus,we identify an
addeddimension to signal processingwherein theoutput response
to an external stimulus is additionally filtered through indicators
that define the phenotypic status of the cell.
The prototypic mitogen-activated protein kinase (MAPK)4
pathway consists of a three-tiered module composed of a
MAPK (ERK1/2), which is activated via phosphorylation by a
MAPK kinase (MEK1/2), which in turn is phosphorylated by
aMAPK kinase kinase (Raf). This pathway exists in all eukaryotic
organisms and controls fundamental cellular processes such as
proliferation, differentiation, migration, survival, and apoptosis
(1–3). Importantly, the cascade arrangement of this module per-
mits integration of a wide range of conserved cellular process,
thereby enabling a precise control of the amplitude, kinetics, and
duration of ERK1/2 (ERK) activation. Several studies have docu-
mented that it is the ability to modulate these individual parame-
tersofERKactivationthatconfers signalingspecificity to thispath-
way in terms of regulating the cellular response (4–7).
The contrast between the apparent biochemical simplicity of
this pathway and the range of complex cellular functions that it
controls has prompted extensive investigations on the struc-
ture and regulation of this pathway. One approach toward this
goal has been through computationalmodeling of this pathway.
The earliest model by Huang and Ferrell (8) demonstrated that
ERK activation exhibited ultrasensitivity and that this was pri-
marily due to the distributive mechanism involved in the dual
phosphorylation of ERK (9). Subsequent to these pioneering
findings, an increasing number ofmodels that have gained both
in size and complexity have been developed over the years. The
various aspects examined by these models include feedback
cooperativity and inhibition, hysteresis, oscillations, Ras activa-
tion, scaffolding proteins, signal specificity, and robustness
among others (10–13). From the standpoint of input/output
relationships, these models have provided important new
insights on feedback, sequestration, and scaffolding influences
on the ERK response (14–17).
A less explored aspect of MAPK regulation, however, has
been the role of phosphatases in regulating signal specificity
(18). An earlier study by Bhalla et al. (19) identified MAPK
phosphatase (MKP) as the locus of flexibility that regulated
between monostable and bistable regimes of operation. More
recently, the protein tyrosine phosphates SHP-1 was shown to
be critical for defining the ligand discrimination threshold of
the ERK response in T lymphocytes (20). Nonetheless, in view
of themultiple phosphatases known to be associated with com-
ponents of the MAPK pathway, a more integrated view of how
such phosphatases regulate input/output relationships is pres-
ently lacking (21).
Our earlier study in murine B lymphoma A20 cells had
demonstrated that the B cell antigen receptor (BCR)-
dependent phosphorylation profiles of all the three constit-
uents of the MAPK module (i.e. Raf MEK1/2 and ERK1/2)
were profoundly influenced when cells were depleted of a
range of cellular phosphatases by siRNA (22). Interestingly,
depending upon the phosphatase depleted, these effects
were either positive or negative, suggesting diverse modes of
regulation. Therefore, in the present study we integrated
these experimental data with existing literature to generate a
mathematical model for ERK phosphorylation. The resulting
model revealed an additional level of regulation of theMAPK
pathway that was enforced through the parallel alignment of
a cascade of phosphatases. Importantly, the cross-talk
between the MAPK and the phosphatases cascade led to the
assembly of a novel regulatory motif that enabled indepen-
dent calibration of signal at each successive node. As a result,
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signal transmission through the MAPK pathway was nonlin-
ear, leading to a combinatorial expansion of the landscape of
potential output responses. Significantly, in addition to
parameters such as signal strength and duration, the bounds
of this landscape also incorporated variations in the relative
levels (or activities) of the associated phosphatases. Thus,
our studies identify a novel processing principle, the result of
which the signal output represents an integrated expression
of the properties of the stimulus and the phenotypic status of
the cell.
EXPERIMENTAL PROCEDURES
Model Building and Numerical Simulations—A complete
description of model building and details of the reaction
scheme and parameters including rate equations for each of the
reactions is provided in supplemental data S1A (description of
model) and S1B (model content, parameters, reaction, and their
rates, initial conditions). All reactionswere converted intomol-
ecule-molecule interactions defining either binding interac-
tions or catalytic reactions. We have used Simbiology2.2
(Mathworks) on MATLAB7.5 as a platform for implementing
the model and for carrying out numerical simulations. All cal-
culations except for that of restimulation experiments were
done using ode15s, which is a solver for stiff differential equa-
tions and differential algebraic equations. It uses the variable
order method based on numerical differentiation formula for
stiff differential equations. Restimulation experiments were
done using Sundials solver CVODE provided with Simbiology.
Parameters were either taken from literature or estimated. Esti-
mation of unknown parameters was done either by iteratively
fitting to the experimental constraints or by using local optimi-
zation with lsqnonlin and lsqcurvefit (wherever experimental
data were available for immediate readout). Sensitivity analysis
of the complete model was done by using SBML_SAT (23), a
freely available SBML-based MATLAB toolbox.
Stimulation of Cells and Detection of Phosphoproteins—A20
cells (1 107/ml) were stimulated with the F(ab)2 fragment of
goat anti-mouse IgG at a final concentration of 25 g/ml in
RPMI for a period of up to 30 min (24). At appropriate times
aliquots of cells were collected and centrifuged, and the cell
pellets were stored in liquid nitrogen. When required, cells
were lysed, the detergent-soluble proteins were resolved by
SDS-PAGE, and specific proteins and phosphoproteins were
detected (and quantified) by Western blot using the procedure
and antibodies as previously described (25).
Co-immunoprecipitation—Lysates were prepared from 2 
107 cells/group/time point in a buffer containing a mixture of
protease and phosphatase inhibitors as previously described
(24). Lysates were precleared with protein A-agarose and then
incubated with appropriate antibody (0.6–1mg at 4 °C for 2 h),
after which the immune complexes were precipitated with
protein A-Sepharose. The immunoprecipitates were identi-
fied by immunoblotting with specific antibodies (Santa Cruz
Biotechnology).
Overexpression of MKP3 in A20 Cells—MKP3 was overex-
pressed as a Strep-tag II fusion protein inA20 cells (26). For this
the cDNA was cloned into the pEXPR-IBA103 vector and then
transfected into cells by electroporation. Subsequent selection
for neomycin resistance over a 4-week period yielded stably
transfected cells. A Western blot analysis revealed that these
cells expressed about 2-fold higher levels of MKP3 when com-
pared with untransfected A20 cells.
Confocal Microscopy; Staining and Image Analysis—Immu-
nofluorescence stainingwas performed following the standard-
ized protocol reported previously (Kumar et al. (22)). Stained
cells were observed with a Nikon TE 2000E microscope
equipped with 60/1.4NA PlanApochromat differential inter-
ference contrast objective lens. Secondary antibodies tagged
either with Alexa 488 or Alexa 568 were excited at 488 and 543
nm with an argon ion and a helium-neon laser, respectively.
The emissions were recorded through emission filters set at
515/30 and 605/75. Serial confocal sections (0.5 m thick)
within a z-stack spanning a total thickness of 10–12 m were
taken in individual channels green and red using the motor
drive focusing system. The transmission and detector gains
were set to achieve the best signal-to-noise ratios, and the
laser powers were tuned to limit bleaching fluorescence. The
refractive index of the immersion oil used was 1.515 (Nikon).
All settings were rigorously maintained for all the experi-
ments. All images were quantified using Image-Pro Plus Ver-
sion 6.0, a commercially available software package from
Media Cybernetics.
The merged confocal images were subjected to co-localiza-
tion analysis to determine the “Overlap Coefficient” proposed
by Manders et al. (27).
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(Eq. 1)
where S1 is signal intensity of pixels in the first channel, and S2
is signal intensity of pixels in the second channel.
At least 18–20 cells were analyzed in 3 sets of experiments
for the co-localization studies. All the images are in the Tiff
RGB 24 format, and phycoerythrin fluorescence has been given
a green pseudocolor. To reduce the unwanted background
noise generated by the photomultiplier signal amplification, all
the image stacks were treated with two-dimensional filters
(Gaussian and sharpening filtering).
RESULTS
Modeling BCR-dependent Activation of the MAPK Network—
The BCR is a hetero-oligomeric transmembrane protein in
which the surface immunoglobulin constitutes the ligand bind-
ing unit, whereas the signaling function is encoded within the
non-covalently associated heterodimer of CD79a and CD79b
(28). Activation of BCR-dependent signaling is mediated by
three distinct cytoplasmic protein tyrosine kinases, which are
Lyn, Syk, and Btk. Activation of Lyn serves as the critical first
step, which then further phosphorylates the immunoreceptor
tyrosine-based activation motifs encoded within the CD79a-
CD79b component of the BCR complex. The activated BCR
subsequently recruits multiple downstream pathways, some of
which include those dependent upon phospholipase C, the
Rho family of GTPases, and the RAS/phosphatidylinositol 3-ki-
nase (for review, see Ref. 29).
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Our previous experimental studies of the plasticity of the
BCR signaling network and its response to specific perturba-
tions (22, 24, 25) provided us with an internally normalized
dataset for modeling salient features of the signaling network.
We, therefore, combined these results with data from the liter-
ature to develop a block diagram for the BCR-activated MAPK
signaling network. Here we specifically included the results
fromourmost recent experiments probing the consequences of
siRNA-mediated depletion of various cellular phosphatases on
BCR-dependent phosphorylation of the constituents of the
MAPK pathway (22). Data generated from the depletion of five
of the tested phosphatases were taken for this study, and these
five phosphatases were PP1, PP2A, MKP1, MKP2, and MKP3.
The selection of these phosphatases was guided by the fact that
MKPs are known regulators of phosphorylation of the interme-
diates in the MAPK pathway (19, 30, 31). Furthermore, Raf,
MEK, MKP1, and MKP3 are all regulated through phosphory-
lation at Ser/Thr residues (30, 32), thereby implicating a possi-
ble role for PP1 and PP2A.
A detailed description of the model development, parameter
estimation, and sensitivity and robustness analyses is provided
in supplemental data S1, A and B, whereas a “line diagram” of
thismodel is depicted in Fig. 1A. Briefly, however, our approach
was divided into two stages. The first involved compilation of
BCR-dependent signaling events through data-mining for pro-
cesses that included immunoreceptor tyrosine-based activa-
tion motif phosphorylation and recruitment of early signaling
intermediates such as Lyn, Syk, B cell linker protein, phospho-
lipase C2, Btk, and phosphatidylinositol 3-kinase up to activa-
tion of the MAPK pathway. In our model we summarized
phosphorylation of the BCR-associated immunoreceptor tyro-
sine-based activation motif as phosphorylated BCR, whereas
the receptor-dependent activation of Lyn and Syk wasmodeled
according to the reported positive feedback system at BCR (33).
Furthermore, we also incorporated the role of the protein-ty-
rosine phosphatase SHP1, which has previously been shown to
function as a negative regulator of Lyn and BCR (24). The phos-
phatidylinositol 3-kinase and inositol signaling system was
modeled by including both B cell adaptor protein- and CD19-
mediated recruitment of the phosphatidylinositol 3-kinase sub-
units. This has been shown to induce both phosphatidylinositol
3-kinase activation and phosphatidylinositol 3-mediated Btk
and Akt recruitment to themembrane, where Akt is phosphor-
ylated by phosphoinositide-dependent protein kinase (29, 34).
On the other hand, at least in B cells, phospholipase C and
RasGTP accumulation ismediated through the scaffolding pro-
tein B cell linker protein and was incorporated in our model
accordingly (34–37). Consistent with the literature, we distin-
guished between the pool of B cell linker protein thatwas bound
to Grb2/Sos and that bound to Btk/phospholipase C at the
level of activation of the downstream pathways. Phospholipase
C-dependent hydrolysis of phosphatidylinositol 2 into diacyl-
glycerol and phosphatidylinositol 1,4,5-trisphosphate results in
the activation of protein kinase C, which along with the Ras-
GTP produced by the B cell linker proteinGrb2SoS complex,
has been shown to constitute an “AND” gate input function for
activation of the MAPK cascade at the level of Raf (MAPK
kinase kinase) (34).
The reaction schemes for recruitment and activation of the
signaling intermediates were strictly in accordance with previ-
ously publishedmodels. In addition to the general schematic of
BCR signal transduction leading to ERK, however, we also
included regulation of the coreMAPKmodule by cellular phos-
phatases. Here, care was taken to incorporate these phospha-
tases in the network in a manner that was consistent with the
known literature information. In instances where adequate
information was not available, assumptions were made on the
basis of our own experimental data. For instance, although pre-
vious reports suggested that MKP1 was primarily localized
within the nucleus of cells (38–40), we found that, at least in
A20 cells, this phosphatase was distributed between both the
cytoplasmic and the nuclear compartments (see supplemental
data S1,A andB). Accordingly, a cytoplasmic pool ofMKP1was
also taken into consideration in our scheme.
The second stage of our model-building exercise involved
several rounds of iterations to ensure that the model accurately
reproduced the experimental dataset. Model parameters such
as initial concentrations, Km and Kd values, and other rate
parameterswere either taken from literature or, whennot avail-
able, were optimized for producing the best experimental fit.
The model was constructed by employing generic rate laws
such asmass action andMichaelis-Menten reaction schemes to
represent the interactions among the various species. The sys-
tem was taken as appropriately modeled when it could fit the
experimental data, which also included our previous findings
on the effects of siRNA-mediated depletion of cellular phos-
phatases on BCR-dependent phosphorylation of ERK (22).
Recapitulation of these latter findings, however, required us to
incorporate two novel interactions for MKP3, wherein in addi-
tion to ERK it was also involved in the dephosphorylation of
both MEK and MKP1. Furthermore, the functional properties
of MKP3 could only be accounted for by postulating that it was
the phosphorylation state of this protein that dictated its rela-
tive substrate specificity for ERK on the one hand andMEK and
MKP1 on the other. Although these aspects are discussed in
more detail later, inclusion of these links provided (over multi-
ple iterations) the unique solution wherein the simulated
results matched well with the experimental data.
Although the resultingmodel was fairly complex, it nonethe-
less encompassed the span of regulatory events emanating from
the receptor and terminating at ERK (Fig. 1, A and B). To test
the model we performed local and global sensitivity analyses
using several independent methods to evaluate the parameters
for their robustness against fluctuations that are normally
inherent to noisy biological conditions. We found that param-
eters to which themodel wasmost sensitive were those that are
already known to be critical for shaping the BCR-specific sig-
naling response (see supplemental data S1,A and B for details).
In other words, our model indeed reflected the true kinetic
properties of BCR-dependent signaling. Parameters specific for
the MAPK-phosphatase module (see Fig. 1B) were robust in
terms of the output behavior and could tolerate a broad range of
perturbations against the ERK activation response. Further-
more, we also verified that the robustness of our model com-
pared well with that of other prominent models described for
theMAPK pathway (see supplemental data S1,A and B). At the
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experimental level, the model also successfully recapitulated
results available in the literature, which included our own ear-
lier experimental data on BCR-dependent signaling inA20 cells
(supplemental Figs. S2 and S3).
Analysis of the Model—The model described in Fig. 1A
exhibited several intriguing topological and dynamical features.
This is especially evident from Fig. 1B, which highlights the
co-alignment of a phosphatase cascade alongside the MAPK
pathway, leading to several cross-regulatory interactions
between the two. Notably, these interactions also included two
novel links for MKP3. That is, in addition to ERK, our model
described MKP3 to also interact with (and negatively regulate)
MEK and MKP1 (Fig. 1B). Furthermore, another related pre-
diction by themodel was thatMKP3-dependent regulation was
tightly controlled through a modulation of its substrate bias. In
other words, whereas phosphorylated MKP3 was described to
FIGURE 1. Signaling through the Lymphocyte receptor induces a novel regulatory motif for MAP kinase activation. A schematic overview of the
reactions for BCR dependent activation ofMAP kinase ERK1/2 is shown in panel A. The highlighted area represents the novel signalingmotif identified and this
is expanded inpanel B. IP3, phosphatidylinositol 1,4,5-trisphosphate;PIP2, phosphatidylinositol 2;PI3K, phosphatidylinositol 3-kinase;DAG, diacylglycerol; PKC,
protein kinase C; BLNK, B cell linker protein; BCAP, B cell adaptor protein.
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exhibit a preference for MEK andMKP1, its non-phosphoryla-
ted form was predicted to be more selective for ERK (see sup-
plemental data S1). As a result, shifts in the distribution of
MKP3 between the phosphorylated and non-phosphorylated
pools potentially served as a mechanism for diversifying the
influence of MKP3 on MAPK signaling.
An in silico prediction of the time-dependent profile of
ERK phosphorylation was consistent with the experimentally
obtained results (Fig. 2A). Furthermore, a similar in silico anal-
ysis of ERK phosphorylation in response to varying ligand con-
centrations yielded an incremental dose-response response
profile (Fig. 2B). This prediction of a graded ERK output could
also be experimentally confirmed by stimulating A20 cells with
increasing concentrations of anti-
IgG (supplemental Fig. S4). Impor-
tantly, ERK response to ligand dose
was found to be graded regardless of
whether it was monitored at the
level of the cell population byWest-
ern blot analysis (Fig. 2C) or at the
level of single cells through intra-
cellular staining for phospho-ERK
and detection by flow cytometry
(Fig. 2D).
Experimental Verification of the
Model—Although our model suc-
cessfully described the activation
profile of several of the incorporated
intermediates in a manner that was
consistent with experimental obser-
vations, we, however, wanted to
further verify some of its novel
topological features. Of particular
interest in this connection was the
identification of two new links for
MKP3. Although the interaction
between MKP3 and ERK is well
known (41–43), ourmodel also pre-
dicted the existence of interactions
ofMKP3with bothMEK andMKP1
(Fig. 1B). It was this ability to regu-
late function of multiple intermedi-
ates that then highlighted MKP3 as
an important regulator of MAPK
signaling. For this we first per-
formed co-immunoprecipitation ex-
periments from lysates of A20 cells
using antibodies specific either for
MEK,MKP1, orMKP3. As shown in
Fig. 3A, immunoprecipitation of
either MEK or MKP1 also led to the
simultaneous enrichment of MKP3,
whereas immunoprecipitates of
MKP3 were enriched for both MEK
and MKP1. Although immunopre-
cipitation results do not permit
quantification, they nonetheless
support at least the existence of
MKP3 in a simultaneous complex with MKP1 and MEK,
thereby confirming the interactions depicted in Fig. 1B. In sub-
sequent experiments we observed that the siRNA-mediated
depletion of MKP3 resulted in a significant (4-fold) increase
in the basal levels of MKP1 (Fig. 3B and supplemental Fig. S4).
These levels were further increased upon stimulation of cells
through the BCR (Fig. 3B). Importantly, this effect of MKP3
could not be inhibited by the inclusion of cycloheximide in the
cultures (supplemental Fig. S4), suggesting that it was the sta-
bility rather than the rate or extent of synthesis of the MKP1
protein that was affected by MKP3-silencing. The stability of
intracellular MKP1 is dictated by its phosphorylation status.
Although the non-phosphorylated form exhibits a short half-
FIGURE 2. The ERK phosphorylation response is proportional to the stimulus strength. Panel A shows the
concordance obtained between experiment (red diamonds, values are themean S.D., n 3) and simulation
(black line) examining the time course of ERK phosphorylation obtained upon stimulation of A20 cells with a
saturating (25g/ml) concentration of anti-IgG. Panel B shows the results of an in silico analysis estimating the
magnitude of ERK phosphorylation (ppERK) obtained after stimulation of cells with varying anti-IgG concen-
trations. Panel C gives the corresponding results of an experiment where A20 cells were stimulated for 10min,
with the indicated doses of anti-IgG. ERK phosphorylation was then determined in lysates by Western blot
analysis (see supplemental Fig. S4). Values are the mean (S.D.) of three independent experiments and are
shown here as normalized raw signal intensity (pSignal intensity). A semi-log plot of these results yielded a Hill
coefficient of 0.6 and 0.56 for simulated and the experimental results, respectively. Stimulated cells were also
subjected to staining for intracellular phospho-ERK using antibodies specific for double-phosphorylated ERK
followedby fluorescein isothiocyanate-labeled secondary antibodies. Stained cellswere thenanalyzedby flow
cytometry, and the results are shown in panel D. Depicted here are the profiles obtained for cells stimulated
with either 0.1 (black line), 0.5 (green line), 5 (pink line), or 25 g/ml (blue line) of anti-IgG. The profile for
unstimulated cells overlappedwith that for cells stimulatedwith 0.1g/ml of ligand. For the negative control,
cells were stained with rabbit IgG instead of the anti-phospho-ERK antibody.
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life, phosphorylation enhances its stability (30). Thus, the
observed inverse relationship betweenMKP3 andMKP1 levels
in Fig. 3B provides additional support for the functional nature
of the link between these two phosphatases. In this connection
it is pertinent to note that under conditions of MKP3 silencing,
the level of both phosphorylated ERK and p38 are significantly
reduced after receptor stimulation (22). Thus, the increased
stability of MKP1 observed here after MKP3 silencing is more
likely due to reduced dephosphorylation of MKP1 by MKP3.
We also verified whether the phosphorylation status of
MKP3 indeed influenced its substrate specificity. For this we
stimulated A20 cells with anti-IgG in the presence of the CK2
inhibitor, DRB (44). As shown in Fig. 1B, MKP3 is primarily
phosphorylated by CK2. Inhibition of this kinase, therefore,
leads to a concomitant inhibition of MKP3 phosphorylation
(32). According to our model then, this should also result in an
increased efficiency of MKP3-mediated dephosphorylation of
ERK. As expected, stimulation of DRB-treated cells led to inhi-
bition of BCR-dependent phosphorylation of ERK (Fig. 3C and
supplemental Fig. S4). These results are also consistent with
previous findings that CK2-dependent phosphorylation of
MKP3 attenuates its inhibitory effect on ERK phosphorylation
(32).
The results in Fig. 3C, therefore, provide experimental sup-
port for our proposal that MKP3 displays differential substrate
specificity depending upon its phosphorylation status. To fur-
ther establish this, however, we also employed an alternate and
more direct approach. Here, A20 cells were stimulated either in
the presence or absence of the CK2 inhibitor, DRB. Subse-
quently, these cells were analyzed by confocal microscopy to
determine the effects of CK2 inhibition on the co-localization
of MKP3 with ERK, MEK, and MKP1. Fig. 4 reveals that in
stimulated cells inhibition of CK2 led to a substantial increase
in the extent of co-localization between MKP3 and ERK. In
contrast, co-localization of MKP3 with both MEK and MKP1
was significantly reduced (Fig. 4). Essentially similar results
were obtained in experiments where, instead of inhibition,
CK2 was also specifically silenced through targeted siRNA
(not shown). At one level these results provide direct evidence
for the novel links between MKP3 and MEK and between
MKP3 and MKP1 identified by our model. In addition to this,
however, the observed alterations in the relative extents of co-
FIGURE 3.Verification of novel interactions incorporated in themodel. In panel A, lysates from stimulated or unstimulated A20 cells were immunoprecipi-
tated with antibodies specific either for MKP3, MEK, or MKP1 (“Experimental Procedures”) (left column, IP). Immunoprecipitates were then subjected to a
Western blot analysis using the antibodies indicated in the right column (WB). As a negative control (ctrl), parallel immunoprecipitateswith rabbit IgGwere also
probedwith the correspondingantibodies.Panel B shows the results ofWesternblot analyses forMKP1 inA20 cells treatedeitherwithMKP3-specific siRNA (red
line) or with non-silencing (i.e.GFP-specific) siRNA (blue line). Stimulation times with anti-IgG (25g/ml) are indicated, and values are themean S.D. of three
separate experiments. We have previously demonstrated that siRNA-mediated silencing of MKP3 results in a70% reduction of this phosphatase protein in
A20 cells (22). In C, the left panel shows the profiles obtained from an in silico analysis in the presence (pink) and absence (blue) of DRB. The right panel shows
the corresponding results obtained experimentally, where cells were treated with or without DRB (20 M) before stimulation with anti-IgG. ppERK, ERK
phosphorylation.
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FIGURE 4. Verifying the MKP3 substrate bias in response to CK2 inhibition. For the experiment, A20 cells were stimulated for 10 min with anti-IgG in the
presenceor absenceof casein kinase inhibitorDRB (20M). Cellswere then fixedand stained for ERK1/2 andMKP3 (toppanel),MEK1/2 andMKP3 (middle panel),
or MKP1 and MKP3 (bottom panel) and observed under laser scanning confocal microscope (“Experimental Procedures”). Merged images for co-localization
between green (ERK1/2, MEK1/2, or MKP1) and red (MKP3) are shown in the figure. The quantitative differences between DRB-treated and -untreated cells for
co-localization with MKP3-MEK1/2, MKP3-ERK1/2, and MKP3-MKP1 upon anti-IgG treatment are shown on the right-hand side. Values are the average (S.E.)
of more than at least 40 cells (***, p 0.0005; **, p 0.005).
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localization of MKP3 with ERK, MEK, and MKP1, induced by
the inhibition of CK2-dependent phosphorylation of MKP3,
also provide experimental confirmation for our proposal that
the substrate specificity ofMKP3 is influenced by its phosphor-
ylation status. Collectively, therefore, the consistency between
predicted and experimentally obtained phosphorylation pro-
files of the various signaling intermediates described above as
well as the experimental confirmation of the new MKP3-de-
pendent regulatory links proposed provide experimental sup-
port for the model depicted in Fig. 1A.
Signal-dependent Assembly of the MAPK Cascade into a
Unique Regulatory Module—Our model described that each
intermediate in the MAPK pathway was under the regulatory
control of both the co-aligned and its immediately upstream
phosphatase. Thus, MEK was regulated by both PP2A and
MKP3, whereas ERK was regulated by MKP3 and MKP1 (Fig.
1B). The MAPK module contained links that collectively
belonged to all of the four possible categories; activation of acti-
vator (protein kinase C to Raf and Raf to MEK), inhibition of
activator (PP2A to Raf andMKP3 toMEK), activation of inhib-
itor (protein kinase C toMKP3 and ERK toMKP1), and inhibi-
tion of inhibitor (PP2A toMKP3 andMKP3 toMKP1/2) (Fig. 1,
A and B).
A significant aspect here was that co-alignment of the two
cascades resulted in the generation of a novel regulatory motif
that was composed of a contiguous set of two square units. The
first of these consisted of Raf, MEK, PP2A, and MKP3 as the
vertices, whereas the second unit involved MEK, ERK, MKP3,
and MKP1 (Fig. 1B). Furthermore, the linkage relationships
between the corresponding vertices were also replicated (Fig.
1B). Interestingly, a closer inspection of this motif revealed that
it was in fact composed of four smaller regulatory units (each
triangle in themotif) that represented alternately placed type-2
coherent and incoherent feed-forward loops (defined as in Ref.
45). A more detailed analysis of these substructures and their
individual contributions to the overall properties of the parent
motif is currently under way as a
separate study. In this report we
focused solely on the role of the
larger motif in regulating signal
processing by the MAPK cascade.
Assembly of this regulatory motif
was dependent upon two separate
input signals originating from the
BCR. The first of these was a protein
kinase C- and RasGTP-dependent
AND gate that mediated Raf activa-
tion in a signal-dependent manner
(19, 46). The second input signal
was defined by the CK2-depen-
dent phosphorylation of MKP3 (Fig.
1B). It has previously been demon-
strated thatMKP3 andCK2 form a
protein complex wherein CK2
specifically phosphorylates MKP3,
with the corresponding increase in
ERK2 phosphorylation (32). As dis-
cussed later, the regulation ofMKP3
between its phosphorylated and non-phosphorylated states has
significant implications for signal processing by the MAPK
pathway. Finally, phosphorylation of MKP1 by ERK was also a
prerequisite for the assembly of thismotif, signifying the impor-
tance of cross-talk between these two cascades in this process.
Phosphatase-mediated Regulation of the ERK Response—We
first examined how the connected network of phosphatases
influenced signal output from the MAPK module. This was
achieved through in silico experiments examining the ligand
dose dependence of ERK phosphorylation under conditions
where the individual phosphatases were depleted one at a time.
Fig. 5 shows the results of these experiments where Normal
depicts the profile obtained in the unperturbed condition. It is
evident that, with the exception of PP1, no other phosphatase
depletion had any significant effect on the proportional nature
of ERK activation (Fig. 5). The observed effect of PP1 depletion
is consistent with our earlier experimental findings involving
depletion of this enzyme by siRNA. In these experiments a
marked decrease in the magnitude of ERK activation was
obtained at the later time points (22). Thus, these results sug-
gest that PP1 may play an important role in buffering the inac-
tive pool of hyperphosphorylated Raf, which is generated by
activated ERK through a positive feedback loop, and Akt
(19, 47, 48).
Depletion of any of the remaining phosphatases resulted only
in amodulation of the amplitude of ERK phosphorylation, with
MKP1 depletion yielding the most pronounced effect (Fig. 5).
Notable, however, were the qualitatively distinct effects seen
upon depletion of the individual, MAPK-associated, phospha-
tases. Suppression of PP2A expression yielded amarginal effect
on the shape of the dose-response curve (Fig. 5), whereas that of
MKP3 resulted in a diminished activation window for ERK due
to a simultaneous increase in sensitivity to lower ligand concen-
trations and a decrease in the peak level that was achieved (Fig.
5). In contrast, removal of MKP2 induced a comparable in-
crease in both the upper and lower bounds of ERK activity (Fig.
FIGURE 5. Phosphatase-mediated regulation of theMAPK signaling response. The influence of individual
phosphatases in sensitizing the ERK output was monitored in silico by analyzing ligand dose versus peak
phospho-ERK (ppERK) levels within the first 30 min of activation. This analysis was performed either in normal
cells (Normal) or in cellswhere the indicatedphosphatasewas depleted from the system. In each case, the -fold
change in ligand concentration required to increase ERK phosphorylation from 10 to 90% of its maximal value
is also given (F). These values confirm that the ERK response remains proportional under all of these conditions.
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5). Thus, individual phosphatases comprising the MAPKmod-
ule exert characteristic influences on the ligand-dependent
dose-response profile of ERK activation.
Perturbation in Phosphatase Concentrations Modulates the
MAPK Response—The output of a signaling network is primar-
ily determined by the topology of the network and the concen-
trations of its nodal constituents. Furthermore, Fig. 5 also con-
firmed that the topological allocation had a significant bearing
in terms of defining the extent of regulation that each phospha-
tase exerted on the MAPK signaling pathway. Therefore, we
next examined how variations in the concentration of these
phosphatases would impact on BCR-initiatedMAPK signaling.
This involved in silico experiments in which the concentration
of the individual phosphatase was varied from one that was
10-fold lower to one that was 10-fold higher than its constitu-
tive level in A20 cells. The phosphorylation of both MEK1/2
and ERK were examined under these conditions.
Although similar experiments were also carried out for PP1
andMKP2 (see supplemental Fig. S5), only the results obtained
for the three phosphatases that are incorporated in the “two-
square” structural motif are shown in Fig. 6. The figure
describes the effect of varying the concentration of these indi-
vidual phosphatases on the peak levels of MEK and ERK phos-
phorylation. Of particular note here was the fact that changing
PP2A concentrations exerted dissimilar effects on MEK and
ERK. A bimodal effect was observed for MEK, and this feature
was retained at all strengths of signal (i.e. ligand doses)
employed (Fig. 6). Contrary to this, ERK yielded a PP2A-de-
pendent bimodal profile only at low ligand concentrations, with
the response to this phosphatase becoming linear as the signal
strength was increased (Fig. 6). Thus, PP2A-mediated regula-
tion yielded non-identical effects on these two consecutively
positioned, signaling intermediates of theMAPKpathway. Fur-
thermore, the extent of deviation in behavior between these
two intermediates was also dependent upon the strength of the
BCR stimulus. Increasing PP2A concentrations also led to a
progressive reduction in the amplitude of both MEK and ERK
responses, although the effect on the latter molecule was more
pronounced (Fig. 6). This aspect could be experimentally veri-
fied by stimulating A20 cells in the presence of the PP2A inhib-
itor okadaic acid. Although okadaic acid is a known inhibitor of
both PP2A and PP1, the 100-fold lower IC50 value for PP2A
allowed us to use a concentration range that was specific for
PP2A.
As shown in supplemental Fig. S6, whereas inhibition of
PP2A activity led to a linear increase in ERK phosphorylation,
that ofMEKdisplayed a bimodal response to PP2A (see also Fig.
8A). The sensitivity of ERK to PP2A activity likely derives from
the concomitant decrease in the size of the pool of non-phos-
phorylated MKP3 as a result of decreasing PP2A levels. As
discussed earlier, thiswould decrease the efficiency ofMKP3-
dependent dephosphorylation of ERK. In addition to this,
however, a diminished pool of phospho-MKP3 would also
imply a consequent reduction in the negative regulation of
MKP1 and, thereby, an increase in the MKP1-dependent
inactivation of ERK.
In similar experiments where MKP3 concentrations were
varied, we observed an inverse relationship between the ampli-
tude of MEK phosphorylation and MKP3 concentrations. In
contrast to this, ERK activation displayed a bell-shaped profile
(Fig. 6). The curvature of the bell was, however, more pro-
nounced at higher ligand concentrations, supporting that ERK
activation remained responsive to the strength of the stimulus.
The bimodal effect of MKP3 on ERK activation again probably
reflects the consequence of concentration-dependent shifts in
the distribution ofMKP3 between its phosphorylated and non-
phosphorylated states. At low concentrations, the non-phos-
phorylated form of MKP3 would predominate due to the dom-
inant action of PP2A. The increased specificity of this form for
ERK can then explain the reduced levels of peak ERKphosphor-
ylation. AsMKP3 levels increase, however, the proportion of its
phosphorylated form is also expected to increase. The conse-
quences of this on ERK activation would then be defined by the
balance of the effects of MKP3 on ERK and that of phospho-
MKP3 on MEK and MKP1. At one level, MKP3 would nega-
tively regulate ERK activity by ensuring its dephosphorylation.
As opposed to this, the phosphorylated subset of MKP3 (phos-
pho-MKP3) would preferentially target MEK and MKP1 but
with opposing consequences. Phospho-MKP3-mediated inac-
tivation of MEK would also inhibit transmission of signal to
ERK. On the other hand, the phospho-MKP3 dependent de-
phosphorylation and resultant destabilization of MKP1 would
lead to attenuation in the negative regulation of ERK by this
enzyme. Consequently, it is the quantitative shifts in balance
between these distinct activities that would then shape the ERK
response to variations in MKP3 concentrations.
Consistentwith expectations, increasingMKP1 levels led to a
steep decline in peak levels of ERK phosphorylation, whereas
the effect on MEK was only marginal (Fig. 6). Thus, the cumu-
lative results in Fig. 6 emphasize that signal-dependent forma-
tion of the two-square motif enables tight regulation of the
MAPK signaling by the associated phosphatases. Importantly,
both quantitative and qualitative aspects of signal transmission
between two consecutive nodes were selectively influenced,
thereby providing amechanismbywhich signal transmission at
the MEK/ERK interface could be further calibrated.
The Phosphatase Axis Orients Signal Processing by theMAPK
Module—Concentrations of phosphatases frequently vary from
one cell type to another. Furthermore, even within a given cell
type, either differences in environmental conditions (histories
of stimulus) and/or developmental stages can lead to significant
changes in intracellular phosphatase concentrations (31, 49,
50). This is particularly true for MKPs in lymphocytes, where
changes either in the activation or differentiation state of the
cell can lead to marked alteration in the relative levels of this
class of phosphatases (31). Thus, given the high connectivity
between the MAPK and the phosphatase cascade, it was rea-
sonable to suspect that variations in the relative concentration
or activity of the MAPK-associated phosphatases would have a
significant impact on signal processing. To explore this we
examined the consequences of simultaneously varying the con-
centration of any two of the three MAPK-associated phospha-
tases while keeping the third at its constitutive level. The effects
on the magnitude of peak phosphorylation of both MEK and
ERK at a fixed ligand dose were monitored. All the three possi-
ble phosphatase combinations were tested over a range of
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10,000 different pairs (in a 100 100matrix) of their respective
concentrations. The range of phosphatase concentrations
employed here was identical to that described for Fig. 6.
Fig. 7A depicts the results of such an exercise in which PP2A
and MKP3 concentrations were varied while keeping MKP1 at
a fixed level. As shown, MEK activity yields a bell-shaped curve
FIGURE 6.Modulation in phosphatase concentrations further shape ligand sensitivity of theMAPK pathway. Peak phosphorylation of ERK (ppERK) andMEK
(ppMEK) was monitored in response to variations in both ligand and individual phosphatase concentrations. Three separate sets of simulation within a defined
concentration windowwere used to reduce the computing time. For each phosphatase, 100 different concentrations of phosphatase were used varying from 10
lower to 10higher (PP2A, 0.0007–0.07M;MKP3, 0.00015–0.015M;MKP1, 0.00002–0.002M) than its constituent concentration level inA20 cells. The combined
data areplottedhere.Panel Aprofiles peakphospho-MEK levels as a combined functionof both varying liganddoses andvarying concentrationsof eachof the three
phosphatases. Here, the top panel shows the three-dimensional plot, whereas the lower panel depicts the same results in the form of a heat map. Similarly, panel B
shows peak phospho-ERK levels as a combined function of both ligand dose and varying concentrations of the three phosphatases.
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in the direction of increasing PP2A levels, although this profile
tends to progressively “flatten” as MKP3 concentrations also
increase. Although the inhibitory effect of MKP3 onMEK acti-
vation was monotonic, it was, however, buffered at high PP2A
concentrations (Fig. 7A). In other words, the relative concen-
trations of PP2A and MKP3 have a significant role to play in
defining the sensitivity of MEK phosphorylation to ligand-in-
duced stimulation of cells. This was also true in the case of ERK,
although here a bimodal activation profile was obtained in the
directions of both increasing PP2A and MKP3 concentrations.
This latter observation suggests the existence of compensatory
effects between these two phosphataseswherebymultiple com-
binations of their respective concentrations yield the same level
of peak ERK activity.
Fig. 7B shows the results of a similar experiment where the
concentrations of MKP3 and MKP1 were varied under condi-
tions where PP2A levels were kept constant. As may be
expected, variations in MKP1 concentrations exerted little or
no effect on peakMEK activity, and the resulting landscape was
heavily biased in favor of the concentration-dependent inhibi-
tory effects of MKP3. In contrast, a bimodal activation curve
was again observed for ERK along the MKP3 axis. The curva-
ture of this profile, however, was stringently controlled by
MKP1, with ERK activation completely inhibited even at mod-
erately higher concentrations of this phosphatase (Fig. 7B).
Similar to the results in Fig. 7A, varying combinations of
PP2A and MKP1 also yielded a bimodal MEK profile in the
direction of PP2A but with a significant reduction in the phos-
phatase concentration window where at least detectable MEK
activation was allowed (Fig. 7C). With the exception of attenu-
ating the amplitude of MEK activation, varying MKP1 levels
had little effect on the profile. Qualitatively similar effects were
also noted for ERK where increasing MKP1 levels served to
further exacerbate the inhibition of ERK activation that was
observed as a function of increasing PP2A levels. However, here
the inhibitory effect of MKP1 was far more pronounced (Fig.
7C). Thus, although the MAPK module functions as a propor-
tional response system, these results emphasize that the net
output is further specified by the relative concentrations of the
individual MAPK-associated phosphatases that are present. In
this connection the assembly of these phosphatases into a reg-
ulatory axis is particularly relevant. As a result, variations in the
concentration gradient along this axis exercise a combinatorial
influence on signal processing by the MAPK pathway.
Finally, another intriguing feature revealed from a cursory
examination of Fig. 7 is the fact that the range of allowed con-
centration regimens of phosphatases was significantly more
restricted for ERK than it was for MEK. This was generally true
for all three pairs of phosphatase combinations studied where
the activation landscape forMEKwas always larger in area than
FIGURE 7. Inter-phosphatase cross-talk regulates signal transmission
through the MAPK pathway. The effects of simultaneous variations in the
concentration SAM-associatedphosphatases onpeakphospho-MEK (ppMEK)
and peak phospho-ERK (ppERK) levels within a 30-min activation window are
shown here. A total of 100 different concentrations were employed for each
phosphatase. These varied from 10 lower to 10 higher than the constitu-
ent concentration inA20cells (PP2A,0.0007–0.07M;MKP3, 0.00015–0.015M;
MKP1, 0.00002–0.002 M). The three combinations shown here are MKP3-
PP2A (A), MKP3-MKP1 (B), and PP2A-MKP1 (C). In each case the top panel
shows peak phospho-MEK levels, whereas the lower panel shows peak phos-
pho-ERK responses. The left and the right panelsdepict the three-dimensional
landscape and the corresponding heatmap representation, respectively. The
corresponding profiles for the remaining components of themodule that are
also regulated by phosphorylation (i.e. Raf, MKP1, and MKP3) are shown in
supplemental Fig. S9.
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that obtained for ERK (Fig. 7). These observations suggest that
the control exerted by the co-aligned phosphatase axis is fur-
ther accentuated during transmission of signal from MEK to
ERK, the effector molecule of the MAPK pathway.
Experimental Support for Signal Processing Function of Phos-
phatase Cascade—Toconfirm the above findings, we examined
as a representative case the consequences of experimentally
modulating MKP3 levels in conjunction with variations in the
concentration of active PP2A. MKP3 levels in A20 cells were
altered either through the use of specific siRNA, which reduces
the amount of the protein by 70% (25), or by stably overex-
pressing it in these cells to achieve a net 2-fold increase in its
concentration (“Experimental Procedures”). To modulate the
concentration of active PP2A, we again employed its inhibitor
okadaic acid. Thus, cells expressing either constitutive, reduced
(through siRNA), or increased (through over-expression) levels
of MKP3 were individually treated with varying okadaic acid
concentrations, and each of these groups was then stimulated
with a range of ligand (i.e. anti-IgG) doses. Peak phosphoryla-
tion levels of bothMEK and ERKwere determined in each case,
and the results obtained are presented in supplemental Figs. S6
and S7.
We first compared these results with the predicted effects on
peak phosphorylation of MEK and ERK of varying levels of the
individual phosphatases shown in Fig. 6. The panel a in Fig. 8A
shows an expanded region of these predicted profiles obtained
at the higher range of ligand doses and over the estimated range
of either MKP3 concentrations or PP2A activities employed in
the present set of experiments (see supplemental Fig. S8). Panel
b of Fig. 8A depicts the experimentally obtained results under
these conditions. A high degree of correspondence between the
simulated and the experimentally derived profiles is clearly evi-
dent here. This was also equally true for peak MEK and ERK
phosphorylation profiles in cells stimulated with suboptimal
doses of the ligand. In addition to this, the data obtained in
supplemental Fig. S6 also served to substantiate the results of
our in silico experiments describing the effects of simulta-
neously varying MKP3 and PP2A levels on the magnitude of
ERK phosphorylation (see Fig. 7A). A comparison of results
from the two approaches is shown in Fig. 8B. Here, panel a
shows the results of our in silico analysis performed by employ-
ing either a high or a suboptimal concentration of ligand for cell
stimulation. The corresponding profiles derived from our
experimental data (supplemental Fig. S7) are shown in panels b
of these figures. A good correlation between results from the
two approaches is again clearly evident here. This was despite
the limited range of concentrations that could feasibly be tested
in the experimental groups. A similar degree of correspondence
was also obtained when experimental and predicted results for
MEK phosphorylation were similarly compared in terms of a
heat map (data not shown).
Thus, by verifying the accuracy of the resulting predictions,
the data in Fig. 8 support the fidelity of the model described
in Fig. 1A. In addition, these findings also firmly establish the
role played by the co-associated phosphatase axis in terms of
calibrating the signal processing capabilities of the MAPK
pathway.
DISCUSSION
The remarkable versatility of the MAPK module is evident
from the fact that ERK activation can display a wide range of
activity profiles depending on the interfaces that regulate signal
transmission through this module. Thus, depending on the cell
type, ERK activation can be ultrasensitive, converting graded
inputs into a digital output response (10). Embedding this path-
way within a positive feedback loop can lead to a dramatic
amplification of signal and also endow it with both bistability
and hysteresis (19). In contrast, a negative feedback loop com-
bined with intrinsic ultrasensitivity brings about sustained
oscillations in ERK phosphorylation (12, 14). The sensitivity of
theMAPKpathway to the cellularmilieu is further underscored
by the fact that under certain conditions it can also function as
amonostable system yielding a proportional output response at
the level of ERK phosphorylation (51–53). At least some of the
determinants of the nature of input/output relationships iden-
tified so far are the concentration of MKPs (19), the concentra-
tion of the scaffolding proteins involved (15), and the extent of
sequestration of ERK in a complex with its kinase,MEK (16). In
addition to defining the threshold between a switch-like versus
a proportional response, these parameters also play a critical
role in modulating the amplitude and kinetics of the output
signal.
In the present case the proportional nature of the input/out-
put relationship, despite incorporating a distributive mecha-
nism for the dual phosphorylation of ERK, appears to be com-
binatorially defined through the relative concentrations/
activities of the MAPK pathway-associated phosphatases.
Thus, in silico exercises involving select modulations in phos-
phatase concentrations yielded an enhanced slope for ERK acti-
vation under conditions where either PP1 orMKP3 levels were
significantly increased (supplemental Fig. S10). Alterations in
levels of the MAPK pathway components had no such effect.
Consistent with this is our experimental demonstration that
siRNA-mediated silencing of these individual phosphatases
had a significant effect on the amplitude, the stability, the kinet-
ics, and the base-line levels of ERK phosphorylation. A role for
filtering spurious noise by MAPK-associated phosphatases has
also been recently discussed (17).
Our finding that phosphatase-dependent regulation of the
MAPK pathway involves organization of the phosphatases into
a co-aligned cascade was especially interesting. Traditionally,
negative regulation of intracellular signal transduction is con-
ceived to occur as a discrete set of localized interactions
between a phosphatase and its target molecule, and a cascade
organization for phosphatases has not been considered so far
(31, 54). Importantly, this co-alignment resulted in the forma-
tion of a novel regulatory module that was composed of a con-
tiguous set of two square units, with the MAPK constituents
and the phosphatases PP2A,MKP3, andMKP1 constituting the
vertices of these units. We have termed this novel signaling
motif, induced uponBCR-dependent stimulation of cells, as the
signal-activated motif (SAM).
Assembly of the SAM involved two distinct input signals
that, in turn, separately activated the functionally distinct com-
ponents of themodule. The first of these involved the combined
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action of protein kinase C and RasGTP to activate Raf, thereby
initiating signal flow through the MAPK cascade. The second
signal, on the other hand, involved the CK2-dependent phos-
phorylation of MKP3. This event was critical to the regulatory
function of the phosphatase axis. Thus, whereas BCR activation
activated signal flow through the MAPK pathway on the one
hand, it also simultaneously embedded this pathway within a
regulatory module so that the net signal output could be care-
fully regulated.
Central to the functioning of the SAMwas the distribution of
MKP3 between its phosphorylated and non-phosphorylated
states where the balance between these two forms was defined
by the reciprocal actions of the constitutively active PP2A and
the signal- activated CK2. This segregation of input signals to
activate both the positive and negative regulatory components
of the SAM motif provided the mechanism by which filtration
and appropriate calibration of the signal output could be
achieved. Key to this was the differential substrate bias dis-
played by phosphorylated and non-phosphorylated MKP3,
with the relative proportion of these two subsets being gov-
erned by the extent to which the input signal (i.e. activated
CK2) could buffer the action of PP2A. The conditional shifts
in the equilibriumbetween these two pools played a critical role
in defining the signal output in terms of the ERK activation
profile. In other words this ability to modulate substrate pref-
erences enabled MKP3 to function as an additional response
element for signal discrimination whereby both signal ampli-
tude and sensitivity to ligand concentration could be further
tuned.
Our subsequent analysis of how output responses were
shaped by alterations in phosphatase concentrations also pro-
vided interesting new insights into the properties of the SAM.
Although MKP3 levels were important in defining the ampli-
tude of ERK activation, it was the MKP1 concentrations that
strictly defined the window of ERK activation. That output reg-
ulation involved the coordinated action of associated phospha-
tases was also emphasized in our studies examining the effect of
simultaneously varying concentrations of two phosphatases.
For example, the available levels of the remaining two phospha-
tases further modulated the effects of varying MKP3 concen-
trations. This was equally true for PP2A and MKP1, thereby
reaffirming the signal-dependent assembly of these phospha-
tases into a functional axis that intimately regulates signal
processing.
The net outcome of the coordinated action of phosphatases
was that information flow through the MAPK pathway did not
occur in a linear fashion. Rather, signal was differentially pro-
cessed at each intermediate in the pathway. Consequently, in
addition to the strength of the stimulus, transmission of signal
between successive nodes was also rendered sensitive to the
relative concentrations of the associated phosphatases. Thus,
for example, conditions yielding a potent activation ofMEKdid
not necessarily translate into a similar profile for ERK. Instead,
signal transmission from MEK to ERK was additionally regu-
lated by the activity and/or concentration of the two remaining
phosphatase components of the SAM. The resultant combina-
torial effects then ranged from a marked amplification to a
complete suppression of ERK activation. Indeed even the lim-
ited investigations performedhere reveal how the intricate cou-
pling of a kinase with a phosphatase axis can provide for flexible
regimes of regulation where the activity and/or concentrations
of the participating phosphatases make key contributions to
calibration of the signal output. A direct consequence of this
was an expanded landscape of potential ERK responses where a
given output characterized not only the strength of activating
stimulus but also the phenotypic state of the cell, at least when
characterized in terms of the MAPK-associated phosphatase
milieu.
Differences in the tissue-specific origin of cells are also often
reflected at the level of differences in concentration of the indi-
vidual MKPs. Similarly, variable MKP levels frequently charac-
terize the individual stages of lineage commitment in lympho-
cytes (55). Furthermore, evenwithin a given cell type, activation
of ERK leads to the up-regulation of both MKP1 and MKP3
(31), with the consequent de-sensitization of ERK to any further
stimulation of the cell. Thus, the composition of at least MKPs
within a cell may well provide a phenotypic description of its
activation and/or differentiation status, which then is also
incorporated when defining the ERK output response.
Thus, in summary, our present delineation of an emergent
motif that endows theMAPK pathway with flexible regimes for
modulating signal output provides additional insights into
mechanisms that facilitate information processing by the sig-
naling machinery. At one level, these findings reveal a novel
organizational principle wherein a kinase cascade is intricately
coupled to a regulatory cascade of phosphatases. The resulting
structural motif that links each kinase intermediate to both the
iso-stage and the upstream phosphatase ensures that signal
transmission is subjected to tight scrutiny at every step of the
pathway. This allows the “strength” of the links between the
phosphates axis and the kinase cascade to also function as
determinants of signal processing. As a result, even a simple
proportional response system becomes endowed with the abil-
ity to generate an output that, in addition to signal duration and
strength, is also sensitized to variations in phosphatase concen-
trations and activities. As shown here, for instance, the land-
scape of ERK activation responses that can potentially be gen-
erated as a result of the SAM can fully account for the diversity
FIGURE 8. Experimental confirmation of the systems properties of the MAPK-associated regulatory module. Panel A depicts peak MEK and ERK phos-
phorylation (10 min of stimulation with anti-IgG) levels obtained as a function of changes either in MKP3 or PP2A concentrations as described in the text. For
the profiles obtained in silico (Predicted), the concentration ranges utilized is described in supplemental Fig. S8, whereas the extent of variation in phosphatase
concentration/activity obtained experimentally (Experimental) is described under “Experimental Support for Signal Processing Function of Phosphatase
Cascade.” Theanti-IgGconcentrationsemployed for theexperiment inhigh liganddose (upperpanel)were10 (blue line) and25 (red line)g/ml,whereas for low
liganddose (lower panel), it was 0.05 (blue line) and 0.5 (red line)g/ml.OA, okadaic acid. Panel Bdescribes the effects of combined variations in levels/activities
of both MKP3 and PP2A on the magnitude of ERK phosphorylation. Here again, a comparison between the in silico (Predicted) and the experimentally
(Experimental) obtained results is shown. Although a similarity in profiles between the two groups is clearly evident, the absence of a higher degree of
concordance was primarily due to the limited number of data points in the experimental group. As described in the text, MKP3 levels were varied in the
experimental sets either through specific depletion by siRNA (KD) or by overexpression (OE).
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of cellular responses that this pathway is known to generate.
Furthermore, as noted earlier, differences in the phenotypic
status of cells either at the level of cell type or differentiation
state or with a history of prior stimulations can also be inte-
grated when defining the ERK output response. It, however,
remains to be seen whether such a regulatory module is also
associated with the other pathways of the signaling network.
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